Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03553771
Other study ID # LEPI
Secondary ID
Status Completed
Phase
First received
Last updated
Start date February 7, 2018
Est. completion date July 1, 2021

Study information

Verified date January 2024
Source Microvention-Terumo, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

A French, multicenter, prospective, observational, "real life" assessment of the safety and efficacy of LVIS and LVIS JR devices in the treatment of intracranial aneurysms


Description:

This is a multicenter observational study. Treatment and follow-up visits will be done as per standard of care. The purpose of this study is to collect data on safety of the devices used since the French reimbursement. 130 patients will be enrolled over an 18-month recruitment period. All patients will be followed for at least 12 months.


Recruitment information / eligibility

Status Completed
Enrollment 130
Est. completion date July 1, 2021
Est. primary completion date July 1, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Patient with an intracranial aneurysm for which an endovascular treatment is indicated with the device LVIS or LVIS JR, either scheduled or emergency (" Bail-out stenting ") - Patient or patient's legally authorized representative has been informed about the study and does not oppose the collection of his/her personal data Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Device:
LVIS and LVIS JR
Braided coil assist stents used for aneurysm embolization

Locations

Country Name City State
France CHU Pellgrin Bordeaux
France CHU Caen Caen
France CHU Gabriel Montpied Clermont-Ferrand
France CHU Michallon Grenoble
France Hôpital Bicêtre Le Kremlin-Bicêtre
France CHU Limoges Limoges
France Hôpital Clairval Marseille
France Hôpital de la Timone Marseille
France Hôpital Gui de Chauliac Montpellier
France Hôpital Central de Nancy Nancy
France Hôpital Pasteur 2 Nice
France Hôpital Lariboisière Paris
France Hôpital Pitié-Salpêtrière Paris
France La Fondation Rothschild Paris
France Hôpital Maison Blanche Reims
France Hôpital Nord Saint-Étienne
France Hôpital Foch Suresnes
France Hôpital d'instruction des Armées Saint-Anne Toulon
France Hôpital Purpan Toulouse
France Hôpital Bretonneau Tours

Sponsors (2)

Lead Sponsor Collaborator
Microvention-Terumo, Inc. Clinact

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Mortality Rate 1 year
Primary Morbidity Rate Number of adverse events with clinical impact related to the procedure and/or the device 1 year
Secondary Clinical effectiveness Number of patients with mRS>2 1 year
Secondary Anatomical effectiveness Number of patients with complete occlusion of the treated aneurysm 1 year
Secondary Retreatment rate 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT04870047 - Coating to Optimize Aneurysm Treatment In The New Flow Diverter Generation N/A
Recruiting NCT05968053 - Detection of Microplastics and Nanoplastics in Neurosurgery Patients (DT-MiNi)
Not yet recruiting NCT05665309 - Interest of Pre-operative Use of 3D Printing for Endovascular Treatment of Unruptured Intracranial Aneurysms With Intrasaccular Flow Disruptor N/A
Completed NCT02783339 - Neuroform Atlas Stent for Intracranial Aneurysm Treatment
Withdrawn NCT01194388 - Axium Coil in Completing Endovascular Aneurysm Surgery Study
Completed NCT00071565 - Familial Intracranial Aneurysm Study II N/A
Recruiting NCT05409989 - MicroVention, Inc. Flow Re-Direction Endoluminal Device X (FRED™ X™) Post-Approval Study N/A
Completed NCT03680742 - Contour Neurovascular System - European Pre-Market Unruptured Aneurysm N/A
Completed NCT04872842 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on 100 Regional Medical Centers in China and Population Follow-up Study
Terminated NCT02532517 - Study to Evaluate the Safety and Effectiveness of the CODMAN ENTERPRISE® Vascular Reconstruction Device N/A
Completed NCT03663257 - Study to Evaluate Cerebral AneurysmFlow Results in Occlusion
Recruiting NCT06189950 - Registration Trial of the Intracranial Visualized Stent for the Wide-necked Intracranial Aneurysms:REBRIDGE N/A
Recruiting NCT05608122 - Establishment of Online Registration Platform for Unruptured Intracranial Aneurysms Based on Regional Medical Centers in China and Population Follow-up Study (Phase Ⅱ)
Recruiting NCT03661463 - Unruptured Intracranial Aneurysm Aspirin Trial (UIAAT). Phase 2
Completed NCT02609867 - A Feasibility Study to Evaluate the Safety and Effectiveness of Implantation of Flowise Cerebral Flow Diverter (Flowise) N/A
Active, not recruiting NCT02292017 - Prospective Packing Density With Target Coils I N/A
Active, not recruiting NCT01872741 - Minipterional Versus Pterional Craniotomy N/A
Completed NCT00993057 - Efficiency of Two Glucose Sampling Protocols for Maintenance of Euglycemia Early Phase 1
Completed NCT00777088 - Pipeline for Uncoilable or Failed Aneurysms N/A
Completed NCT00777907 - Complete Occlusion of Coilable Aneurysms Phase 3